Abstract:Background: Individuals with 22q11.2 Deletion Syndrome (22q11.2 DS) are a specific high-risk group for developing schizophrenia (SZ), schizoaffective disorder (SAD) and autism spectrum disorders (ASD). Several genes in the deleted region have been implicated in the development of SZ, e.g., PRODH and DGCR8. However, the mechanistic connection between these genes and the neuropsychiatric phenotype remains unclear. To elucidate the molecular consequences of 22q11.2 deletion in early neural development, we carried out RNA-seq analysis to investigate gene expression in early differentiating human neurons derived from induced pluripotent stem cells (iPSCs) of 22q11.2 DS SZ and SAD patients. Methods: Eight cases (ten iPSC-neuron samples in total including duplicate clones) and seven controls (nine in total including duplicate clones) were subjected to RNA sequencing. Using a systems level analysis, differentially expressed genes/gene-modules and pathway of interests were identified. Lastly, we related our findings from in vitro neuronal cultures to brain development by mapping differentially expressed genes to BrainSpan transcriptomes. Results: We observed ~2-fold reduction in expression of almost all genes in the 22q11.2 region in SZ (37 genes reached p-value < 0.05, 36 of which reached a false discovery rate < 0.05). Outside of the deleted region, 745 genes showed significant differences in expression between SZ and control neurons (p < 0.05). Function enrichment and network analysis of the differentially expressed genes uncovered converging evidence on abnormal expression in key functional pathways, such as apoptosis, cell cycle and survival, and MAPK signaling in the SZ and SAD samples. By leveraging transcriptome profiles of normal human brain tissues across human development into adulthood, we showed that the differentially expressed genes converge on a sub-network mediated by CDC45 and the cell cycle, which would be disrupted by the 22q11.2 deletion during embryonic brain development, and another sub-network modulated by PRODH, which could contribute to disruption of brain function during adolescence. Conclusions: This study has provided evidence for disruption of potential molecular events in SZ patient with 22q11.2 deletion and related our findings from in vitro neuronal cultures to functional perturbations that can occur during brain development in SZ.

An Integrative Analysis of Identified Schizophrenia-Associated Brain Cell Types and Gene Expression Changes

Cell group analysis reveals changes in upper-layer neurons associated with schizophrenia

Overdispersed gene expression characterizes schizophrenic brains

Genetic Insights of Schizophrenia via Single Cell RNA-Sequencing Analyses

Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization.

Overdispersed Gene Expression in Schizophrenia

Gene expression in patient-derived neural progenitors provide insights into neurodevelopmental aspects of schizophrenia

Identification of differentially expressed genes of blood leukocytes for Schizophrenia

Identification of Immune-Related Gene Signature in Schizophrenia

Brain transcriptional regulatory architecture and schizophrenia etiology converge between East Asian and European ancestral populations

Implications of Newly Identified Brain Eqtl Genes and Their Interactors in Schizophrenia

Mapping the Cellular Etiology of Schizophrenia and Diverse Brain Phenotypes

Integrative Transcriptomics Reveals Layer 1 Astrocytes Altered in Schizophrenia

Transcriptomics and proteomics of projection neurons in a circuit linking hippocampus with dorsolateral prefrontal cortex in human brain

Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion

Transcriptomic Causal Networks identified patterns of differential gene regulation in human brain from Schizophrenia cases versus controls

Identification of Potential Blood Biomarkers for Early Diagnosis of Schizophrenia Through RNA Sequencing Analysis

Identifying crucial biomarkers in peripheral blood of schizophrenia and screening therapeutic agents by comprehensive bioinformatics analysis

Whole transcriptome analysis reveals dysregulation of molecular networks in schizophrenia

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Identification of Potential Biomarkers and Their Correlation with Immune Infiltration Cells in Schizophrenia Using Combinative Bioinformatics Strategy.